RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy With Merck’s KEYTRUDA® for Certain Late-Stage Cancers
Jotup,
This image depicts two 90-degree PET arcs that sense tumor emissions to guide radiotherapy delivery.
This image depicts two 90-degree PET arcs that sense tumor emissions to guide radiotherapy delivery.
, a therapeutic oncology company pioneering biology-guided radiotherapy* () for treating all stages of cancer, today announced…
-- RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* ( BgRT ) for treating all stages…
HAYWARD, Calif.--( BUSINESS WIRE )-- RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* …